Answers are grounded in this paper and cite their sources.
Purpose of review The success of antiretroviral therapy (ART) that transformed HIV infection in a chronic clinical condition, and reversed the typical failure to thrive characteristic for HIV disease progression to weight gains, resulted in new challenges for the clinical management of the persons living with HIV (PLWH). Prolonged survival also dramatically increased the average age of PLWH, and the frequency of comorbidities associated with HIV. Most of these clinical challenges stem from the persistent inflammation and accelerated aging characteristic to PLWH, which are also associated with obesity. Recent findings Natural killer (NK) cells, which suffer multiple alterations during HIV infection and in obese people, such as a reduction in the frequency of circulating NK cells, alterations in their surface receptor repertoire and expression, unbalanced anti and proinflammatory profiles, with a dysregulated cytokine production. In the meantime, while NK cells are increasingly activated, their functionality (i.e., cytotoxicity) is impaired and their metabolism is altered in obese individuals and in PLWH. Summary These multiple effects of HIV and obesity on NK cells call for interventions aimed at reversing the immunometabolic reprograming. Multiple such interventions are currently tested, and their impact on the NK cells functionality is still to be evaluated.
No takes yet. Share an insight, caveat, or question.
Beaumont et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: